Pfizer vaccine effective against COVID-19 variants in Japan: study

Around 90 percent of those who received the vaccine developed by U.S. pharmaceutical giant Pfizer Inc. were found to have antibodies against the various COVID-19 variants detected in Japan, a university study showed Wednesday.The study by a research team at Yokohama City University was conducted on 105 people who had received both doses of the vaccine without contracting the novel coronavirus and covered seven variants.Of the 105 people, 90 to 94 percent were found to have antibodies against the variants found in Britain, South Africa and Brazil, while 97 percent had antibodies against the …READ FULL ARTICLE